(Q46365780)
Statements
1 reference
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. (English)
1 reference
1 reference
Ian D Davis
1 reference
Lynette Kiers
1 reference
Lachlan MacGregor
1 reference
Joseph Arezzo
1 reference
Michael Green
1 reference
Mark Rosenthal
1 reference
Michael Chia
1 reference
Michael Michael
1 reference
Peter Bartley
1 reference
Leonie Harrison
1 reference
Michael Daly
1 reference
1 March 2005
1 reference
1 reference
11
1 reference
1890-1898
1 reference
5
1 reference
Identifiers
1 reference
1 reference